Integrative multi-omics analysis reveals probiotic-induced microbiota shifts in women with gestational diabetes
Integrative Multi-Omics-Analyse zeigt probiotikainduzierte Veränderungen der Mikrobiota bei Frauen mit Gestationsdiabetes
Frontiers in Cellular and Infection Microbiology · 16.03.2026 · 16
DOI: 10.3389/fcimb.2026.1782744 ↗Auf einen Blick
Bei Frauen mit Gestationsdiabetes veränderte 8-wöchige Probiotika-Gabe die Darmmikrobiota, Metabolite und Genexpression. Lactobacillus und Bifidobacterium nahmen zu, Escherichia/Shigella nahm ab.
Fragestellung
Welchen Einfluss hat Probiotika-Gabe auf Darmmikrobiota, Metabolom und Genexpression bei Frauen mit Gestationsdiabetes?
Methode
Multi-Omics-Studie bei Frauen mit GDM; 8 Wochen Probiotika; Metagenomik, LC-MS, qRT-PCR; Integration mit PCA, PLS-DA, Netzwerk- und KEGG/MetaboAnalyst-Analyse.
Ergebnisse
Lactobacillus 7,6-fach und Bifidobacterium 6,4-fach höher; Escherichia/Shigella reduziert. Butyrat 3,1-fach und Acetat 2,5-fach höher; Insulinrezeptor 2,5-fach und AKT 1,9-fach höher; TNF-α und IL-6 sanken.
Einschränkungen
Größere Bestätigungsstudien werden von den Autor:innen gefordert.
Schlussfolgerung der Autor:innen
Die Autor:innen folgern, dass Probiotika die Mikrobiota, die metabolische Aktivität und die Genexpression bei Frauen mit GDM deutlich beeinflussen und eine nicht-invasive, sichere Behandlung darstellen könnten.
Kernaussagen
- Lactobacillus 7,6-fach und Bifidobacterium 6,4-fach höher
- Butyrat 3,1-fach und Acetat 2,5-fach höher
- Insulinrezeptor 2,5-fach und AKT 1,9-fach höher
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 16.03.2026. Verfasst von Xiaohua Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Probiotics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Gestational diabetes mellitus (GDM) is a common pregnancy disorder. It is associated with impaired glucose tolerance and insulin resistance, increasing the potential risks for both maternal and fetal complications. GDM is associated with an increased risk of type 2 diabetes later in life. Management is a big issue in maternal health. New work has underscored the role of the gut microbiota in metabolism and immune function. This indicates that probiotics might exert their mode of action through modulating the microbiota and controlling metabolism.
Methods
This study employs a multi-omics strategy to assess the impact of probiotic administration on gut microbiota composition, metabolomic profiles, and host gene expression in GDM women. Women with GDM received probiotics for 8 weeks. Metagenomic sequencing quantified alterations of gut microbiota composition and LC-MS provided untargeted metabolomics in serum and urine. Gene expression was analyzed by qRT-PCR in reference to other physiological factors such as insulin signaling, inflammation, oxidative stress, and gut barrier. Data integration was performed using Principal Component Analysis (PCA), Partial Least Squares Discriminant Analysis (PLS-DA), and network analysis, then pathway enrichment analysis was conducted with KEGG and MetaboAnalyst.
Results
The supplementation of probiotics resulted in a significant change of gut microbiota (Lactobacillus 7.6-fold; Bifidobacterium 6.4-fold). Escherichia/Shigella was reduced. The amounts of short-chain fatty acids (SCFAs), especially butyrate and acetate, were increased 3.1 fold and 2.5 fold, respectively. In a gene expression assessment, the insulin receptor and AKT increased 2.5- and 1.9-fold higher, respectively, indicating greater insulin sensitivity. Levels of TNF-α and IL-6 decreased; however, genes related to gut barrier function (ZO-1, CLDN1) increased.
Discussion
The administration of probiotic has a great impact on gut microbiome, metabolic activity, and host gene expression in women with GDM. Our data indicate that probiotics may represent a non-invasive and safe treatment for gestational diabetes through enhancing insulin sensitivity, anti-inflammatory environment, and gut health status. Larger confirmatory studies are needed to corroborate these findings and augment future clinical application of probiotics in GDM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China.
- Department of Gynecology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
- Department of Obstetrics, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Zitieren
APA
Su, X., Yang, J., Le, Z., Xiao, J., & Zhao, D. (2026). Integrative multi-omics analysis reveals probiotic-induced microbiota shifts in women with gestational diabetes. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1782744
Vancouver
Su X, Yang J, Le Z, Xiao J, Zhao D. Integrative multi-omics analysis reveals probiotic-induced microbiota shifts in women with gestational diabetes. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1782744
BibTeX
@article{Su2026,
author = {Su, Xiaohua and Yang, Jindi and Le, Zhen and Xiao, Jingwen and Zhao, Daoyan},
title = {Integrative multi-omics analysis reveals probiotic-induced microbiota shifts in women with gestational diabetes},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1782744}
}
EUVIMED